Pretreatment plasma osteopontin level as a marker of response to curative radiotherapy and hormonal treatment for prostate cancer
Based on the obtained results, we assume that the level of OPN measured before the start of radiotherapy may be an independent predictor of OS of patients with prostate cancer treated with radiotherapy with and without ADT.
Authors
- Beata Smolska-Ciszewska (ORCID: https://orcid.org/0000-0002-0859-6326)
- Rafał Suwiński (ORCID: https://orcid.org/0000-0002-3895-7938)
- Jolanta Mrochem‐Kwarciak (ORCID: https://orcid.org/0000-0002-4267-8608)
- Regina Deja (ORCID: https://orcid.org/0000-0002-2560-4893)
- Katarzyna Karczmarczyk
Institutions
- National Institute of Oncology (HU)
Publication Details
- Journal
- Radiotherapy and Oncology
- Published
- 2024-08-31
- DOI
- https://doi.org/10.1016/j.radonc.2024.110518
- Citations
- 4
- Primary Topic
- Urological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.14